Practice Areas & Industries: Mayer Brown LLP

 





Group Profile Lawyers in this Group Offices Locations for this Group
 

Practice/Industry Group Overview

We have melded the significant resources, experience and legal skills of our attorneys to find innovative and practice approaches for our clients in complex health care markets.

We offer our clients a full range of corporate services including mergers, acquisitions, development of health maintenance organizations, joint ventures and other forms of affiliation for health care systems. Our regulatory work covers Medicare and Medicaid fraud and abuse, reimbursement concerns, insurance subrogation analyses, FDA matters, medical staff issues, corporate compliance plans and other federal and state regulatory issues. We have extensive experience in information technology and e-commerce work, intellectual property, finance, securitizations, as well as restructurings, health benefit plan issues, tax planning, and real estate. We act as bond counsel and counsel to underwriters and banks in health care bond financings, and serve as counsel in health care initial public offerings.

We represent a number of major health care corporations in criminal and civil litigation including complex trial work and appellate and Supreme Court matters. Our health care litigation experience includes defense of complex class action litigation including toxic torts, medical device products liability, civil and criminal antitrust, RICO, consumer fraud and deceptive practices, alleged violations of food and drug laws, state Attorneys General matters, and securities fraud cases. We have extensive experience in matters covering complex health insurance reimbursement, intellectual property litigation, bankruptcy, Food Drug and Cosmetic Act, and ERISA cases. We counsel numerous clients regarding health care reform developments on the national and state levels, and provide expert advice concerning the Americans With Disabilities Act.

HIPAA Resources

  • Medicare HIPAA Documents
  • Proposed Rule - Security and Electronic Signature Standards
  • Final Rule - Standards for Privacy of Individually Identifiable Health Information
  • Part 1 | Part 2 | Part 3 | Part 4 | Part 5 | Part 6 | Part 7 | Part 8

Additional HIPAA Resources

  • National Council for Prescription Drug Programs (NCPDP)
  • WEDI SNIP
  • Washington Publishing

 
Group Presentations
Affordable Care Act Cases, Andrew J. Pincus, Speaker, April 2, 2012
Constitutionality of the Health Care Reform Law, Charles A. Rothfeld, Speaker, March 20, 2012
Health Care Law Oral Argument Preview, Andrew J. Pincus, Speaker , March 13, 2012
 
Past Seminar Materials
Outsourcing Klinischer Studien, Dr. Adem Koyuncu , Dr. Michael Herschel, GlaxoSmithKline; Dr. Hans-Joachim Lau, MedDevConsult; Holger Stammer, Pharmalog Institut für klinische Forschung; Prof. Dr. Frank Wagner, Charité Research Organisation, Speakers, January 30, 2013
Outsourcing Klinischer Studien, Dr. Adem Koyuncu , Dr. Michael Herschel, GlaxoSmithKline; Dr. Hans-Joachim Lau, MedDevConsult; Holger Stammer, Pharmalog Institut für klinische Forschung; Prof. Dr. Frank Wagner, Charité Research Organisation, Speakers, December 6, 2012